Industry Research Reports
Global Peptide APIs Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 88 Pages
Report ld: 2818285
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Fully extensible peptide active pharmaceutical ingredients (apis) from early clinical to commercial products because the different physiological parts of peptides make them appropriate support masters changes.There is a broad array of physiological activities influenced by bioactive peptides, and these biological activities are controlled by the type, number, progression, and nature of the amino acids shown in the peptides.
The global Peptide APIs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Peptide APIs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Peptide APIs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Peptide APIs is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Peptide APIs include CordenPharma, PolyPeptide, Bachem, AmbioPharm, Pepscan, BCN Peptides and Senn Chemicals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Peptide APIs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Peptide APIs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Peptide APIs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peptide APIs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Peptide APIs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Peptide APIs sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- CordenPharma
- PolyPeptide
- Bachem
- AmbioPharm
- Pepscan
- BCN Peptides
- Senn Chemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Liquid Phase Peptide Synthesis (LPPS)
- Solid Phase Peptide Synthesis (SPPS)
Segment by Application
- Cancer
- Diabetes
- Obesity
- Fertility
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Peptide APIs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Peptide APIs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide APIs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Peptide APIs Product Introduction
1.2 Market by Type
1.2.1 Global Peptide APIs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liquid Phase Peptide Synthesis (LPPS)
1.2.3 Solid Phase Peptide Synthesis (SPPS)
1.3 Market by Application
1.3.1 Global Peptide APIs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Obesity
1.3.5 Fertility
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peptide APIs Sales Estimates and Forecasts 2019-2030
2.2 Global Peptide APIs Revenue by Region
2.2.1 Global Peptide APIs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Peptide APIs Revenue by Region (2019-2024)
2.2.3 Global Peptide APIs Revenue by Region (2025-2030)
2.2.4 Global Peptide APIs Revenue Market Share by Region (2019-2030)
2.3 Global Peptide APIs Sales Estimates and Forecasts 2019-2030
2.4 Global Peptide APIs Sales by Region
2.4.1 Global Peptide APIs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Peptide APIs Sales by Region (2019-2024)
2.4.3 Global Peptide APIs Sales by Region (2025-2030)
2.4.4 Global Peptide APIs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Peptide APIs Sales by Manufacturers
3.1.1 Global Peptide APIs Sales by Manufacturers (2019-2024)
3.1.2 Global Peptide APIs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide APIs in 2023
3.2 Global Peptide APIs Revenue by Manufacturers
3.2.1 Global Peptide APIs Revenue by Manufacturers (2019-2024)
3.2.2 Global Peptide APIs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Peptide APIs Revenue in 2023
3.3 Global Key Players of Peptide APIs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Peptide APIs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Peptide APIs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Peptide APIs, Product Offered and Application
3.8 Global Key Manufacturers of Peptide APIs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peptide APIs Sales by Type
4.1.1 Global Peptide APIs Historical Sales by Type (2019-2024)
4.1.2 Global Peptide APIs Forecasted Sales by Type (2025-2030)
4.1.3 Global Peptide APIs Sales Market Share by Type (2019-2030)
4.2 Global Peptide APIs Revenue by Type
4.2.1 Global Peptide APIs Historical Revenue by Type (2019-2024)
4.2.2 Global Peptide APIs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Peptide APIs Revenue Market Share by Type (2019-2030)
4.3 Global Peptide APIs Price by Type
4.3.1 Global Peptide APIs Price by Type (2019-2024)
4.3.2 Global Peptide APIs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Peptide APIs Sales by Application
5.1.1 Global Peptide APIs Historical Sales by Application (2019-2024)
5.1.2 Global Peptide APIs Forecasted Sales by Application (2025-2030)
5.1.3 Global Peptide APIs Sales Market Share by Application (2019-2030)
5.2 Global Peptide APIs Revenue by Application
5.2.1 Global Peptide APIs Historical Revenue by Application (2019-2024)
5.2.2 Global Peptide APIs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Peptide APIs Revenue Market Share by Application (2019-2030)
5.3 Global Peptide APIs Price by Application
5.3.1 Global Peptide APIs Price by Application (2019-2024)
5.3.2 Global Peptide APIs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Peptide APIs Market Size by Type
6.1.1 US & Canada Peptide APIs Sales by Type (2019-2030)
6.1.2 US & Canada Peptide APIs Revenue by Type (2019-2030)
6.2 US & Canada Peptide APIs Market Size by Application
6.2.1 US & Canada Peptide APIs Sales by Application (2019-2030)
6.2.2 US & Canada Peptide APIs Revenue by Application (2019-2030)
6.3 US & Canada Peptide APIs Market Size by Country
6.3.1 US & Canada Peptide APIs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Peptide APIs Sales by Country (2019-2030)
6.3.3 US & Canada Peptide APIs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Peptide APIs Market Size by Type
7.1.1 Europe Peptide APIs Sales by Type (2019-2030)
7.1.2 Europe Peptide APIs Revenue by Type (2019-2030)
7.2 Europe Peptide APIs Market Size by Application
7.2.1 Europe Peptide APIs Sales by Application (2019-2030)
7.2.2 Europe Peptide APIs Revenue by Application (2019-2030)
7.3 Europe Peptide APIs Market Size by Country
7.3.1 Europe Peptide APIs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Peptide APIs Sales by Country (2019-2030)
7.3.3 Europe Peptide APIs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Peptide APIs Market Size
8.1.1 China Peptide APIs Sales (2019-2030)
8.1.2 China Peptide APIs Revenue (2019-2030)
8.2 China Peptide APIs Market Size by Application
8.2.1 China Peptide APIs Sales by Application (2019-2030)
8.2.2 China Peptide APIs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Peptide APIs Market Size by Type
9.1.1 Asia Peptide APIs Sales by Type (2019-2030)
9.1.2 Asia Peptide APIs Revenue by Type (2019-2030)
9.2 Asia Peptide APIs Market Size by Application
9.2.1 Asia Peptide APIs Sales by Application (2019-2030)
9.2.2 Asia Peptide APIs Revenue by Application (2019-2030)
9.3 Asia Peptide APIs Sales by Region
9.3.1 Asia Peptide APIs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Peptide APIs Revenue by Region (2019-2030)
9.3.3 Asia Peptide APIs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Peptide APIs Market Size by Type
10.1.1 Middle East, Africa and Latin America Peptide APIs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Peptide APIs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Peptide APIs Market Size by Application
10.2.1 Middle East, Africa and Latin America Peptide APIs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Peptide APIs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Peptide APIs Sales by Country
10.3.1 Middle East, Africa and Latin America Peptide APIs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Peptide APIs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Peptide APIs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CordenPharma
11.1.1 CordenPharma Company Information
11.1.2 CordenPharma Overview
11.1.3 CordenPharma Peptide APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 CordenPharma Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CordenPharma Recent Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Overview
11.2.3 PolyPeptide Peptide APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 PolyPeptide Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 PolyPeptide Recent Developments
11.3 Bachem
11.3.1 Bachem Company Information
11.3.2 Bachem Overview
11.3.3 Bachem Peptide APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bachem Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bachem Recent Developments
11.4 AmbioPharm
11.4.1 AmbioPharm Company Information
11.4.2 AmbioPharm Overview
11.4.3 AmbioPharm Peptide APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 AmbioPharm Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AmbioPharm Recent Developments
11.5 Pepscan
11.5.1 Pepscan Company Information
11.5.2 Pepscan Overview
11.5.3 Pepscan Peptide APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Pepscan Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pepscan Recent Developments
11.6 BCN Peptides
11.6.1 BCN Peptides Company Information
11.6.2 BCN Peptides Overview
11.6.3 BCN Peptides Peptide APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 BCN Peptides Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BCN Peptides Recent Developments
11.7 Senn Chemicals
11.7.1 Senn Chemicals Company Information
11.7.2 Senn Chemicals Overview
11.7.3 Senn Chemicals Peptide APIs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Senn Chemicals Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Senn Chemicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peptide APIs Industry Chain Analysis
12.2 Peptide APIs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peptide APIs Production Mode & Process
12.4 Peptide APIs Sales and Marketing
12.4.1 Peptide APIs Sales Channels
12.4.2 Peptide APIs Distributors
12.5 Peptide APIs Customers
13 Market Dynamics
13.1 Peptide APIs Industry Trends
13.2 Peptide APIs Market Drivers
13.3 Peptide APIs Market Challenges
13.4 Peptide APIs Market Restraints
14 Key Findings in The Global Peptide APIs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Peptide APIs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Liquid Phase Peptide Synthesis (LPPS)
Table 3. Major Manufacturers of Solid Phase Peptide Synthesis (SPPS)
Table 4. Global Peptide APIs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Peptide APIs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Peptide APIs Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Peptide APIs Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Peptide APIs Revenue Market Share by Region (2019-2024)
Table 9. Global Peptide APIs Revenue Market Share by Region (2025-2030)
Table 10. Global Peptide APIs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Peptide APIs Sales by Region (2019-2024) & (Tons)
Table 12. Global Peptide APIs Sales by Region (2025-2030) & (Tons)
Table 13. Global Peptide APIs Sales Market Share by Region (2019-2024)
Table 14. Global Peptide APIs Sales Market Share by Region (2025-2030)
Table 15. Global Peptide APIs Sales by Manufacturers (2019-2024) & (Tons)
Table 16. Global Peptide APIs Sales Share by Manufacturers (2019-2024)
Table 17. Global Peptide APIs Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Peptide APIs Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Peptide APIs, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Peptide APIs Price by Manufacturers 2019-2024 (USD/MT)
Table 21. Global Peptide APIs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Peptide APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide APIs as of 2023)
Table 23. Global Key Manufacturers of Peptide APIs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Peptide APIs, Product Offered and Application
Table 25. Global Key Manufacturers of Peptide APIs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 28. Global Peptide APIs Sales by Type (2025-2030) & (Tons)
Table 29. Global Peptide APIs Sales Share by Type (2019-2024)
Table 30. Global Peptide APIs Sales Share by Type (2025-2030)
Table 31. Global Peptide APIs Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Peptide APIs Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Peptide APIs Revenue Share by Type (2019-2024)
Table 34. Global Peptide APIs Revenue Share by Type (2025-2030)
Table 35. Peptide APIs Price by Type (2019-2024) & (USD/MT)
Table 36. Global Peptide APIs Price Forecast by Type (2025-2030) & (USD/MT)
Table 37. Global Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 38. Global Peptide APIs Sales by Application (2025-2030) & (Tons)
Table 39. Global Peptide APIs Sales Share by Application (2019-2024)
Table 40. Global Peptide APIs Sales Share by Application (2025-2030)
Table 41. Global Peptide APIs Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Peptide APIs Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Peptide APIs Revenue Share by Application (2019-2024)
Table 44. Global Peptide APIs Revenue Share by Application (2025-2030)
Table 45. Peptide APIs Price by Application (2019-2024) & (USD/MT)
Table 46. Global Peptide APIs Price Forecast by Application (2025-2030) & (USD/MT)
Table 47. US & Canada Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 48. US & Canada Peptide APIs Sales by Type (2025-2030) & (Tons)
Table 49. US & Canada Peptide APIs Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Peptide APIs Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 52. US & Canada Peptide APIs Sales by Application (2025-2030) & (Tons)
Table 53. US & Canada Peptide APIs Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Peptide APIs Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Peptide APIs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Peptide APIs Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Peptide APIs Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 59. US & Canada Peptide APIs Sales by Country (2025-2030) & (Tons)
Table 60. Europe Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 61. Europe Peptide APIs Sales by Type (2025-2030) & (Tons)
Table 62. Europe Peptide APIs Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Peptide APIs Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 65. Europe Peptide APIs Sales by Application (2025-2030) & (Tons)
Table 66. Europe Peptide APIs Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Peptide APIs Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Peptide APIs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Peptide APIs Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Peptide APIs Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 72. Europe Peptide APIs Sales by Country (2025-2030) & (Tons)
Table 73. China Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 74. China Peptide APIs Sales by Type (2025-2030) & (Tons)
Table 75. China Peptide APIs Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Peptide APIs Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 78. China Peptide APIs Sales by Application (2025-2030) & (Tons)
Table 79. China Peptide APIs Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Peptide APIs Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 82. Asia Peptide APIs Sales by Type (2025-2030) & (Tons)
Table 83. Asia Peptide APIs Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Peptide APIs Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 86. Asia Peptide APIs Sales by Application (2025-2030) & (Tons)
Table 87. Asia Peptide APIs Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Peptide APIs Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Peptide APIs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Peptide APIs Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Peptide APIs Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Peptide APIs Sales by Region (2019-2024) & (Tons)
Table 93. Asia Peptide APIs Sales by Region (2025-2030) & (Tons)
Table 94. Middle East, Africa and Latin America Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 95. Middle East, Africa and Latin America Peptide APIs Sales by Type (2025-2030) & (Tons)
Table 96. Middle East, Africa and Latin America Peptide APIs Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Peptide APIs Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 99. Middle East, Africa and Latin America Peptide APIs Sales by Application (2025-2030) & (Tons)
Table 100. Middle East, Africa and Latin America Peptide APIs Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Peptide APIs Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Peptide APIs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Peptide APIs Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Peptide APIs Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 106. Middle East, Africa and Latin America Peptide APIs Sales by Country (2025-2030) & (Tons)
Table 107. CordenPharma Company Information
Table 108. CordenPharma Description and Major Businesses
Table 109. CordenPharma Peptide APIs Sales (Tons), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. CordenPharma Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CordenPharma Recent Developments
Table 112. PolyPeptide Company Information
Table 113. PolyPeptide Description and Major Businesses
Table 114. PolyPeptide Peptide APIs Sales (Tons), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. PolyPeptide Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. PolyPeptide Recent Developments
Table 117. Bachem Company Information
Table 118. Bachem Description and Major Businesses
Table 119. Bachem Peptide APIs Sales (Tons), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 120. Bachem Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bachem Recent Developments
Table 122. AmbioPharm Company Information
Table 123. AmbioPharm Description and Major Businesses
Table 124. AmbioPharm Peptide APIs Sales (Tons), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 125. AmbioPharm Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. AmbioPharm Recent Developments
Table 127. Pepscan Company Information
Table 128. Pepscan Description and Major Businesses
Table 129. Pepscan Peptide APIs Sales (Tons), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 130. Pepscan Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Pepscan Recent Developments
Table 132. BCN Peptides Company Information
Table 133. BCN Peptides Description and Major Businesses
Table 134. BCN Peptides Peptide APIs Sales (Tons), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 135. BCN Peptides Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. BCN Peptides Recent Developments
Table 137. Senn Chemicals Company Information
Table 138. Senn Chemicals Description and Major Businesses
Table 139. Senn Chemicals Peptide APIs Sales (Tons), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 140. Senn Chemicals Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Senn Chemicals Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Peptide APIs Distributors List
Table 145. Peptide APIs Customers List
Table 146. Peptide APIs Market Trends
Table 147. Peptide APIs Market Drivers
Table 148. Peptide APIs Market Challenges
Table 149. Peptide APIs Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide APIs Product Picture
Figure 2. Global Peptide APIs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Peptide APIs Market Share by Type in 2023 & 2030
Figure 4. Liquid Phase Peptide Synthesis (LPPS) Product Picture
Figure 5. Solid Phase Peptide Synthesis (SPPS) Product Picture
Figure 6. Global Peptide APIs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Peptide APIs Market Share by Application in 2023 & 2030
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Obesity
Figure 11. Fertility
Figure 12. Other
Figure 13. Peptide APIs Report Years Considered
Figure 14. Global Peptide APIs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Peptide APIs Revenue 2019-2030 (US$ Million)
Figure 16. Global Peptide APIs Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Peptide APIs Revenue Market Share by Region (2019-2030)
Figure 18. Global Peptide APIs Sales 2019-2030 ((Tons)
Figure 19. Global Peptide APIs Sales Market Share by Region (2019-2030)
Figure 20. US & Canada Peptide APIs Sales YoY (2019-2030) & (Tons)
Figure 21. US & Canada Peptide APIs Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Peptide APIs Sales YoY (2019-2030) & (Tons)
Figure 23. Europe Peptide APIs Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Peptide APIs Sales YoY (2019-2030) & (Tons)
Figure 25. China Peptide APIs Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Asia (excluding China) Peptide APIs Sales YoY (2019-2030) & (Tons)
Figure 27. Asia (excluding China) Peptide APIs Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Peptide APIs Sales YoY (2019-2030) & (Tons)
Figure 29. Middle East, Africa and Latin America Peptide APIs Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Peptide APIs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. The Top 5 and 10 Largest Manufacturers of Peptide APIs in the World: Market Share by Peptide APIs Revenue in 2023
Figure 32. Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Peptide APIs Sales Market Share by Type (2019-2030)
Figure 34. Global Peptide APIs Revenue Market Share by Type (2019-2030)
Figure 35. Global Peptide APIs Sales Market Share by Application (2019-2030)
Figure 36. Global Peptide APIs Revenue Market Share by Application (2019-2030)
Figure 37. US & Canada Peptide APIs Sales Market Share by Type (2019-2030)
Figure 38. US & Canada Peptide APIs Revenue Market Share by Type (2019-2030)
Figure 39. US & Canada Peptide APIs Sales Market Share by Application (2019-2030)
Figure 40. US & Canada Peptide APIs Revenue Market Share by Application (2019-2030)
Figure 41. US & Canada Peptide APIs Revenue Share by Country (2019-2030)
Figure 42. US & Canada Peptide APIs Sales Share by Country (2019-2030)
Figure 43. U.S. Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Peptide APIs Sales Market Share by Type (2019-2030)
Figure 46. Europe Peptide APIs Revenue Market Share by Type (2019-2030)
Figure 47. Europe Peptide APIs Sales Market Share by Application (2019-2030)
Figure 48. Europe Peptide APIs Revenue Market Share by Application (2019-2030)
Figure 49. Europe Peptide APIs Revenue Share by Country (2019-2030)
Figure 50. Europe Peptide APIs Sales Share by Country (2019-2030)
Figure 51. Germany Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 52. France Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 53. U.K. Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 54. Italy Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 55. Russia Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 56. China Peptide APIs Sales Market Share by Type (2019-2030)
Figure 57. China Peptide APIs Revenue Market Share by Type (2019-2030)
Figure 58. China Peptide APIs Sales Market Share by Application (2019-2030)
Figure 59. China Peptide APIs Revenue Market Share by Application (2019-2030)
Figure 60. Asia Peptide APIs Sales Market Share by Type (2019-2030)
Figure 61. Asia Peptide APIs Revenue Market Share by Type (2019-2030)
Figure 62. Asia Peptide APIs Sales Market Share by Application (2019-2030)
Figure 63. Asia Peptide APIs Revenue Market Share by Application (2019-2030)
Figure 64. Asia Peptide APIs Revenue Share by Region (2019-2030)
Figure 65. Asia Peptide APIs Sales Share by Region (2019-2030)
Figure 66. Japan Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 67. South Korea Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 68. China Taiwan Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 69. Southeast Asia Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 70. India Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Peptide APIs Sales Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Peptide APIs Revenue Market Share by Type (2019-2030)
Figure 73. Middle East, Africa and Latin America Peptide APIs Sales Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Peptide APIs Revenue Market Share by Application (2019-2030)
Figure 75. Middle East, Africa and Latin America Peptide APIs Revenue Share by Country (2019-2030)
Figure 76. Middle East, Africa and Latin America Peptide APIs Sales Share by Country (2019-2030)
Figure 77. Brazil Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 78. Mexico Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 79. Turkey Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 80. Israel Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 81. GCC Countries Peptide APIs Revenue (2019-2030) & (US$ Million)
Figure 82. Peptide APIs Value Chain
Figure 83. Peptide APIs Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Peptide APIs market?
The top companies in the global Peptide APIs market are CordenPharma、PolyPeptide、Bachem.
Related Reports
Global Peptide APIs Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Peptide APIs market is projected to grow from US$ 7912 million in 2025 to US$ 13760 million by 2032, at a CAGR of 8.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 180
USD 4900.00
(Single User License)
Global Peptide APIs Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Peptide APIs market size was US$ 7912 million in 2025 and is forecast to reach a readjusted size of US$ 13760 million by 2032 with a CAGR of 8.4% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 102
USD 4250.00
(Single User License)
Peptide APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peptide APIs was estimated to be worth US$ 7912 million in 2025 and is projected to reach US$ 13760 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 146
USD 3950.00
(Single User License)
Global Peptide APIs Market Research Report 2026
The global Peptide APIs market was valued at US$ 7912 million in 2025 and is anticipated to reach US$ 13760 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 147
USD 2900.00
(Single User License)
Peptide APIs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide APIs was estimated to be worth US$ 7243 million in 2024 and is forecast to a readjusted size of US$ 12801 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-12-05
Pages: 137
USD 3950.00
(Single User License)
Global Peptide APIs Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peptide APIs market is projected to grow from US$ 7243 million in 2024 to US$ 12801 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-12-05
Pages: 175
USD 4900.00
(Single User License)
Global Peptide APIs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Peptide APIs market size was US$ 7243 million in 2024 and is forecast to a readjusted size of US$ 12801 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published Date: 2025-12-05
Pages: 109
USD 4250.00
(Single User License)
Global Peptide APIs Market Research Report 2025
The global market for Peptide APIs was valued at US$ 7243 million in the year 2024 and is projected to reach a revised size of US$ 12801 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published Date: 2025-12-05
Pages: 109
USD 2900.00
(Single User License)
Peptide APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide APIs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 104
USD 3950.00
(Single User License)
Global Peptide APIs Market Research Report 2024
Fully extensible peptide active pharmaceutical ingredients (apis) from early clinical to commercial products because the different physiological parts of peptides make them appropriate support masters changes.There is a broad array of physiological activities influenced by bioactive peptides, and these biological activities are controlled by the type, number, progression, and nature of the amino acids shown in the peptides.
Published Date: 2024-01-11
Pages: 81
USD 2900.00
(Single User License)
Global Peptide APIs Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Peptide APIs market is projected to grow from US$ 7912 million in 2025 to US$ 13760 million by 2032, at a CAGR of 8.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 180
USD 4900.00 (Single User License)Global Peptide APIs Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Peptide APIs market size was US$ 7912 million in 2025 and is forecast to reach a readjusted size of US$ 13760 million by 2032 with a CAGR of 8.4% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 102
USD 4250.00 (Single User License)Peptide APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peptide APIs was estimated to be worth US$ 7912 million in 2025 and is projected to reach US$ 13760 million, growing at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-03-05
Pages: 146
USD 3950.00 (Single User License)Global Peptide APIs Market Research Report 2026
The global Peptide APIs market was valued at US$ 7912 million in 2025 and is anticipated to reach US$ 13760 million by 2032, at a CAGR of 8.4% from 2026 to 2032.
Published: 2026-03-05
Pages: 147
USD 2900.00 (Single User License)Peptide APIs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide APIs was estimated to be worth US$ 7243 million in 2024 and is forecast to a readjusted size of US$ 12801 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-12-05
Pages: 137
USD 3950.00 (Single User License)Global Peptide APIs Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peptide APIs market is projected to grow from US$ 7243 million in 2024 to US$ 12801 million by 2031, at a CAGR of 8.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-12-05
Pages: 175
USD 4900.00 (Single User License)Global Peptide APIs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Peptide APIs market size was US$ 7243 million in 2024 and is forecast to a readjusted size of US$ 12801 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.
Published: 2025-12-05
Pages: 109
USD 4250.00 (Single User License)Global Peptide APIs Market Research Report 2025
The global market for Peptide APIs was valued at US$ 7243 million in the year 2024 and is projected to reach a revised size of US$ 12801 million by 2031, growing at a CAGR of 8.4% during the forecast period.
Published: 2025-12-05
Pages: 109
USD 2900.00 (Single User License)Peptide APIs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide APIs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 104
USD 3950.00 (Single User License)Global Peptide APIs Market Research Report 2024
Fully extensible peptide active pharmaceutical ingredients (apis) from early clinical to commercial products because the different physiological parts of peptides make them appropriate support masters changes.There is a broad array of physiological activities influenced by bioactive peptides, and these biological activities are controlled by the type, number, progression, and nature of the amino acids shown in the peptides.
Published: 2024-01-11
Pages: 81
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now